I agree with you about looking ahead mate. It just needs to be done with some reasonable analysis of where the money comes from to fund those expansions. A $3-5b market cap needs at least the 25 ktpa operation to get there, and that requires around A$1b CAPEX, almost five times AGY's current market cap. So I'm just looking for a compelling reason for how AGY reaches that point without massive dilution.
To add context, LAAC are currently ramping up their 40 ktpa operation at Cauchari-Olaroz, and they have a market cap of US$800m (A$1.225b). I'm keen to understand how AGY, with no funding arrangement in place for their 10 ktpa expansion, can be expected to triple the market cap of an operation in the same country that is almost four times the size, and is already funded, constructed and ramping up.
- Forums
- ASX - By Stock
- AGY
- General Discussion AGY
General Discussion AGY, page-21382
-
- There are more pages in this discussion • 1,872 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.5¢ |
Change
-0.008(8.60%) |
Mkt cap ! $123.7M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 8.5¢ | $362.9K | 4.093M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 93664 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 0.085 |
3 | 99873 | 0.084 |
4 | 169062 | 0.083 |
3 | 336585 | 0.082 |
2 | 114691 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 93664 | 1 |
0.088 | 232558 | 1 |
0.089 | 69615 | 2 |
0.090 | 91167 | 2 |
0.091 | 52101 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online